You likely know the general pressure on hospitals due to the pandemic led to delays for elective surgeries.

But that dynamic is reversing as COVID case loads subside.

That’s good news for two large medical products companies that are well-positioned in robotics and for the acceleration in elective surgeries.

Related stories: Four Companies with Pricing Power